Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02208635 · ClinicalTrials.gov registry record · NA

Absorption of Zinc (Zn) From Zn-biofortified and Zn-fortified Maize in Young Zambian Children Between 24-36 Months

A NA study, sponsored by University of Colorado, Denver.

Completed
Registry status
NA
Development phase
60
Enrollment target

NCT02208635: Completed NA study, sponsored by University of Colorado, Denver.

NCT02208635 is a NA study that has completed, run by University of Colorado, Denver. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02208635, a NA study, has completed, sponsored by University of Colorado, Denver.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target

Study Summary

The objective of this study is to compare the quantity of Zn absorbed from an accurately weighed quantity (\~100 g) of minimally milled control maize (\~15 µg Zn/g maize), from biofortified maize (\~30 µg Zn/g) and from the same control maize that has been fortified (total level of \~60 µg Zn/g) when fed to young children age 24-36 months whose major habitual food staple is maize.

Primary Outcome

Absorption of zinc will be measured in young children fed a diet of control, Zn-biofortified, or Zn-fortified maize. Fractional absorption of zinc from all meals of the day will be measured by extrinsic labeling with stable isotopes of zinc. Fractional absorption of zinc will be measured by a dual isotope tracer ratio technique. Measurement of total zinc in duplicate diets on test day will allow determination of quantity of this micronutrient absorbed (mg/d).

Interventions

  • OTHER Biofortified Maize
  • OTHER Fortified Maize
  • OTHER Control Maize

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2012-10
Est. Completion 2015-12
Phase NA
University of Colorado, Denver

1,283 total trials

What the finished NCT02208635 record still lists

NCT02208635 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 3 interventions - of which Biofortified Maize is the first listed.

NCT02208635 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02208635 about?

NCT02208635 is a clinical study titled "Absorption of Zinc (Zn) From Zn-biofortified and Zn-fortified Maize in Young Zambian Children Between 24-36 Months". The objective of this study is to compare the quantity of Zn absorbed from an accurately weighed quantity (\~100 g) of minimally milled control maize (\~15 µg Zn/g maize), from biofortified maize (\~30 µg Zn/g) and from the same control maize that has been fortified (total level of \~60 µg Zn/g) whe...

What is the current status of trial NCT02208635?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2012-10. Estimated completion is 2015-12.

What interventions are being tested in trial NCT02208635?

The interventions under investigation include: Biofortified Maize (OTHER), Fortified Maize (OTHER), Control Maize (OTHER).

Who is sponsoring clinical trial NCT02208635?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02208635's enrollment target sits among peer trials

60 1164th of 2000 higher than 745 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02208635, the US trial registry maintained by the National Library of Medicine. NCT02208635 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.